Can a copper intrauterine device (IUD) be used in a woman with endometriosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Copper IUD Use in Women with Endometriosis

A copper IUD can be used in women with endometriosis, though it is not the preferred intrauterine device option for this population. According to the U.S. Medical Eligibility Criteria, copper IUDs are classified as Category 2 for endometriosis, meaning the advantages generally outweigh theoretical risks, but the levonorgestrel-releasing IUD (LNG-IUD) is Category 1 (no restrictions) and offers therapeutic benefits 1.

Key Clinical Considerations

IUD Selection in Endometriosis

  • The LNG-IUD is superior to copper IUD for women with endometriosis because it provides both contraception and symptom relief, decreasing dysmenorrhea, pelvic pain, and dyspareunia 1.

  • Copper IUDs may worsen dysmenorrhea, which is already a common symptom in endometriosis patients 1. The Category 2 classification reflects this concern—while not contraindicated, copper IUDs are not ideal when better alternatives exist.

  • For severe dysmenorrhea specifically, copper IUDs receive a Category 2 rating (compared to Category 1 for LNG-IUD), as dysmenorrhea may intensify with copper IUD use 1.

Evidence on Copper IUD Effects

  • Copper does not provide therapeutic benefit for endometriosis symptoms 1. Research shows copper alters endometrial gene expression and affects 49 genes related to endometrial receptivity, including 19 genes involved in endometriosis pathology, though the clinical significance remains unclear 2.

  • Longitudinal population data demonstrates that copper IUDs do not influence dysmenorrhea severity (neither worsening nor improving it), while LNG-IUS significantly reduces dysmenorrhea severity 3.

When Copper IUD May Be Appropriate

Consider copper IUD in endometriosis patients when:

  • The patient has contraindications to hormonal contraception (Category 1 for copper IUD vs. Category 4 for LNG-IUD with current breast cancer) 1, 4.

  • The patient specifically desires hormone-free contraception and accepts that symptoms may not improve 1.

  • The patient requires emergency contraception, as copper IUD can be used within 5 days of unprotected intercourse 5.

Common Pitfalls to Avoid

  • Do not assume all IUDs are equivalent for endometriosis management—the hormonal component of LNG-IUD provides therapeutic benefit beyond contraception 1.

  • Counsel patients that copper IUDs will not improve endometriosis-related pain and may potentially worsen menstrual cramping 1.

  • Screen for dysmenorrhea severity before insertion—patients with severe baseline dysmenorrhea may experience worsening symptoms with copper IUD 1.

Practical Management Algorithm

For women with endometriosis seeking contraception:

  1. First-line recommendation: LNG-IUD (Category 1) for combined contraception and symptom management 1.

  2. If hormonal contraception contraindicated: Copper IUD is acceptable (Category 2) but counsel about lack of symptom benefit 1, 4.

  3. If severe dysmenorrhea present: Strongly favor LNG-IUD over copper IUD 1.

  4. Monitor for worsening symptoms: If dysmenorrhea intensifies after copper IUD insertion, consider switching to LNG-IUD or alternative management 6.

Related Questions

What are the recommended management options for post‑menopausal endometriosis, including medical and surgical therapies?
What is the recommended diagnostic workup for suspected endometriosis, including history, pelvic exam, imaging, laboratory tests, and definitive laparoscopy?
Can a woman who had a hysterectomy for endometriosis but retained only one ovary develop recurrent endometriosis two years after the surgery?
What are the typical laparoscopic findings in endometriosis?
In a 27-year-old nulligravida who stopped oral contraceptives 8 months ago, has regular intercourse, heavy menstrual bleeding and dysmenorrhea relieved by ibuprofen, what is the appropriate initial diagnostic study to evaluate for endometriosis?
Is there an association between 5‑fluorouracil (5‑FU) and mitomycin C and cutaneous infection, cellulitis, or skin necrosis?
What is the recommended taper schedule for a patient with bipolar disorder currently taking 1000 mg nightly of Depakote (valproate) ER?
How should dystrophic calcification that developed after multiple surgeries and repeated trauma be managed?
When can sexual intercourse be safely resumed after completing trichomoniasis treatment with metronidazole (or tinidazole) and being symptom‑free?
What laboratory tests should be ordered to evaluate a 2‑year‑old child with frequent voiding, nighttime enuresis, and clear dilute urine for possible diabetes insipidus?
What are the expected follicle‑stimulating hormone (FSH) and luteinizing hormone (LH) levels in a healthy 55‑year‑old man?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.